APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Selected research

Market Analysis & Forecast

Global Glucagon Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchGlucagon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucagon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

This report presents an overview of global market for Glucagon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Glucagon, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glucagon sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glucagon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glucagon sales, projected growth trends, production technology, application and end-user industry.

Glucagon Segment by Company

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

Glucagon Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Segment by Application

Emergency Kits

General Use

Diagnostic & Motility

Cardiogenic Shock

Others

Glucagon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Glucagon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glucagon Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inject Glucagon Major Manufacturers Table 3. Nasal Glucagon Major Manufacturers Table 4. Global Glucagon Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Emergency Kits Major Manufacturers Table 6. General Use Major Manufacturers Table 7. Diagnostic & Motility Major Manufacturers Table 8. Cardiogenic Shock Major Manufacturers Table 9. Others Major Manufacturers Table 10. Glucagon Industry Trends Table 11. Glucagon Industry Drivers Table 12. Glucagon Industry Opportunities and Challenges Table 13. Glucagon Industry Restraints Table 14. Global Glucagon Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Glucagon Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Glucagon Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Glucagon Revenue Market Share by Region (2021-2026) Table 18. Global Glucagon Revenue Market Share by Region (2027-2032) Table 19. Global Glucagon Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K MT) Table 20. Global Glucagon Sales by Region (2021-2026) & (K MT) Table 21. Global Glucagon Sales by Region (2027-2032) & (K MT) Table 22. Global Glucagon Sales Market Share by Region (2021-2026) Table 23. Global Glucagon Sales Market Share by Region (2027-2032) Table 24. Global Glucagon Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Glucagon Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Glucagon Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Glucagon Sales Market Share by Manufacturers (2021-2026) Table 28. Global Glucagon Sales Price (USD/MT) of Manufacturers (2021-2026) Table 29. Global Glucagon Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Glucagon Manufacturers, Product Type & Application Table 32. Global Glucagon Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Glucagon by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Glucagon Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Glucagon Revenue Market Share by Type (2021-2026) Table 39. Global Glucagon Revenue Market Share by Type (2027-2032) Table 40. Global Glucagon Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 41. Global Glucagon Sales by Type (2021-2026) & (K MT) Table 42. Global Glucagon Sales by Type (2027-2032) & (K MT) Table 43. Global Glucagon Sales Market Share by Type (2021-2026) Table 44. Global Glucagon Sales Market Share by Type (2027-2032) Table 45. Global Glucagon Price by Type (2021-2026) & (USD/MT) Table 46. Global Glucagon Price by Type (2027-2032) & (USD/MT) Table 47. Global Glucagon Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Glucagon Revenue Market Share by Application (2021-2026) Table 51. Global Glucagon Revenue Market Share by Application (2027-2032) Table 52. Global Glucagon Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 53. Global Glucagon Sales by Application (2021-2026) & (K MT) Table 54. Global Glucagon Sales by Application (2027-2032) & (K MT) Table 55. Global Glucagon Sales Market Share by Application (2021-2026) Table 56. Global Glucagon Sales Market Share by Application (2027-2032) Table 57. Global Glucagon Price by Application (2021-2026) & (USD/MT) Table 58. Global Glucagon Price by Application (2027-2032) & (USD/MT) Table 59. Novo Nordisk Company Information Table 60. Novo Nordisk Business Overview Table 61. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 62. Novo Nordisk Glucagon Product Portfolio Table 63. Novo Nordisk Recent Development Table 64. Eli Lilly Company Information Table 65. Eli Lilly Business Overview Table 66. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 67. Eli Lilly Glucagon Product Portfolio Table 68. Eli Lilly Recent Development Table 69. Fresenius Kabi Company Information Table 70. Fresenius Kabi Business Overview Table 71. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 72. Fresenius Kabi Glucagon Product Portfolio Table 73. Fresenius Kabi Recent Development Table 74. Torrent Labs Company Information Table 75. Torrent Labs Business Overview Table 76. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 77. Torrent Labs Glucagon Product Portfolio Table 78. Torrent Labs Recent Development Table 79. Taj Pharmaceuticals Company Information Table 80. Taj Pharmaceuticals Business Overview Table 81. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 82. Taj Pharmaceuticals Glucagon Product Portfolio Table 83. Taj Pharmaceuticals Recent Development Table 84. Xeris Pharmaceuticals Company Information Table 85. Xeris Pharmaceuticals Business Overview Table 86. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 87. Xeris Pharmaceuticals Glucagon Product Portfolio Table 88. Xeris Pharmaceuticals Recent Development Table 89. North America Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Glucagon Sales by Type (2021-2026) & (K MT) Table 92. North America Glucagon Sales by Type (2027-2032) & (K MT) Table 93. North America Glucagon Sales Price by Type (2021-2026) & (USD/MT) Table 94. North America Glucagon Sales Price by Type (2027-2032) & (USD/MT) Table 95. North America Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Glucagon Sales by Application (2021-2026) & (K MT) Table 98. North America Glucagon Sales by Application (2027-2032) & (K MT) Table 99. North America Glucagon Sales Price by Application (2021-2026) & (USD/MT) Table 100. North America Glucagon Sales Price by Application (2027-2032) & (USD/MT) Table 101. North America Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Glucagon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. North America Glucagon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. North America Glucagon Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 105. North America Glucagon Sales by Country (2021-2026) & (K MT) Table 106. North America Glucagon Sales by Country (2027-2032) & (K MT) Table 107. North America Glucagon Sales Price by Country (2021-2026) & (USD/MT) Table 108. North America Glucagon Sales Price by Country (2027-2032) & (USD/MT) Table 109. United States Glucagon Revenue (2021-2032) & (US$ Million) Table 110. Canada Glucagon Revenue (2021-2032) & (US$ Million) Table 111. Mexico Glucagon Revenue (2021-2032) & (US$ Million) Table 112. Europe Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Glucagon Sales by Type (2021-2026) & (K MT) Table 115. Europe Glucagon Sales by Type (2027-2032) & (K MT) Table 116. Europe Glucagon Sales Price by Type (2021-2026) & (USD/MT) Table 117. Europe Glucagon Sales Price by Type (2027-2032) & (USD/MT) Table 118. Europe Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Glucagon Sales by Application (2021-2026) & (K MT) Table 121. Europe Glucagon Sales by Application (2027-2032) & (K MT) Table 122. Europe Glucagon Sales Price by Application (2021-2026) & (USD/MT) Table 123. Europe Glucagon Sales Price by Application (2027-2032) & (USD/MT) Table 124. Europe Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Glucagon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. Europe Glucagon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. Europe Glucagon Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 128. Europe Glucagon Sales by Country (2021-2026) & (K MT) Table 129. Europe Glucagon Sales by Country (2027-2032) & (K MT) Table 130. Europe Glucagon Sales Price by Country (2021-2026) & (USD/MT) Table 131. Europe Glucagon Sales Price by Country (2027-2032) & (USD/MT) Table 132. Germany Glucagon Revenue (2021-2032) & (US$ Million) Table 133. France Glucagon Revenue (2021-2032) & (US$ Million) Table 134. U.K. Glucagon Revenue (2021-2032) & (US$ Million) Table 135. Italy Glucagon Revenue (2021-2032) & (US$ Million) Table 136. Russia Glucagon Revenue (2021-2032) & (US$ Million) Table 137. Spain Glucagon Revenue (2021-2032) & (US$ Million) Table 138. Netherlands Glucagon Revenue (2021-2032) & (US$ Million) Table 139. Switzerland Glucagon Revenue (2021-2032) & (US$ Million) Table 140. Sweden Glucagon Revenue (2021-2032) & (US$ Million) Table 141. Poland Glucagon Revenue (2021-2032) & (US$ Million) Table 142. China Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 143. China Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 144. China Glucagon Sales by Type (2021-2026) & (K MT) Table 145. China Glucagon Sales by Type (2027-2032) & (K MT) Table 146. China Glucagon Sales Price by Type (2021-2026) & (USD/MT) Table 147. China Glucagon Sales Price by Type (2027-2032) & (USD/MT) Table 148. China Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 149. China Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 150. China Glucagon Sales by Application (2021-2026) & (K MT) Table 151. China Glucagon Sales by Application (2027-2032) & (K MT) Table 152. China Glucagon Sales Price by Application (2021-2026) & (USD/MT) Table 153. China Glucagon Sales Price by Application (2027-2032) & (USD/MT) Table 154. Asia Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Glucagon Sales by Type (2021-2026) & (K MT) Table 157. Asia Glucagon Sales by Type (2027-2032) & (K MT) Table 158. Asia Glucagon Sales Price by Type (2021-2026) & (USD/MT) Table 159. Asia Glucagon Sales Price by Type (2027-2032) & (USD/MT) Table 160. Asia Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Glucagon Sales by Application (2021-2026) & (K MT) Table 163. Asia Glucagon Sales by Application (2027-2032) & (K MT) Table 164. Asia Glucagon Sales Price by Application (2021-2026) & (USD/MT) Table 165. Asia Glucagon Sales Price by Application (2027-2032) & (USD/MT) Table 166. Asia Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Glucagon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Asia Glucagon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Asia Glucagon Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 170. Asia Glucagon Sales by Country (2021-2026) & (K MT) Table 171. Asia Glucagon Sales by Country (2027-2032) & (K MT) Table 172. Asia Glucagon Sales Price by Country (2021-2026) & (USD/MT) Table 173. Asia Glucagon Sales Price by Country (2027-2032) & (USD/MT) Table 174. Japan Glucagon Revenue (2021-2032) & (US$ Million) Table 175. South Korea Glucagon Revenue (2021-2032) & (US$ Million) Table 176. India Glucagon Revenue (2021-2032) & (US$ Million) Table 177. Australia Glucagon Revenue (2021-2032) & (US$ Million) Table 178. Taiwan Glucagon Revenue (2021-2032) & (US$ Million) Table 179. Southeast Asia Glucagon Revenue (2021-2032) & (US$ Million) Table 180. SAMEA Glucagon Revenue by Type (2021-2026) & (US$ Million) Table 181. SAMEA Glucagon Revenue by Type (2027-2032) & (US$ Million) Table 182. SAMEA Glucagon Sales by Type (2021-2026) & (K MT) Table 183. SAMEA Glucagon Sales by Type (2027-2032) & (K MT) Table 184. SAMEA Glucagon Sales Price by Type (2021-2026) & (USD/MT) Table 185. SAMEA Glucagon Sales Price by Type (2027-2032) & (USD/MT) Table 186. SAMEA Glucagon Revenue by Application (2021-2026) & (US$ Million) Table 187. SAMEA Glucagon Revenue by Application (2027-2032) & (US$ Million) Table 188. SAMEA Glucagon Sales by Application (2021-2026) & (K MT) Table 189. SAMEA Glucagon Sales by Application (2027-2032) & (K MT) Table 190. SAMEA Glucagon Sales Price by Application (2021-2026) & (USD/MT) Table 191. SAMEA Glucagon Sales Price by Application (2027-2032) & (USD/MT) Table 192. SAMEA Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. SAMEA Glucagon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. SAMEA Glucagon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. SAMEA Glucagon Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 196. SAMEA Glucagon Sales by Country (2021-2026) & (K MT) Table 197. SAMEA Glucagon Sales by Country (2027-2032) & (K MT) Table 198. SAMEA Glucagon Sales Price by Country (2021-2026) & (USD/MT) Table 199. SAMEA Glucagon Sales Price by Country (2027-2032) & (USD/MT) Table 200. Brazil Glucagon Revenue (2021-2032) & (US$ Million) Table 201. Argentina Glucagon Revenue (2021-2032) & (US$ Million) Table 202. Chile Glucagon Revenue (2021-2032) & (US$ Million) Table 203. Colombia Glucagon Revenue (2021-2032) & (US$ Million) Table 204. Peru Glucagon Revenue (2021-2032) & (US$ Million) Table 205. Saudi Arabia Glucagon Revenue (2021-2032) & (US$ Million) Table 206. Israel Glucagon Revenue (2021-2032) & (US$ Million) Table 207. UAE Glucagon Revenue (2021-2032) & (US$ Million) Table 208. Turkey Glucagon Revenue (2021-2032) & (US$ Million) Table 209. Iran Glucagon Revenue (2021-2032) & (US$ Million) Table 210. Egypt Glucagon Revenue (2021-2032) & (US$ Million) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Glucagon Distributors List Table 214. Glucagon Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Glucagon Image Figure 2. Global Glucagon Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inject Glucagon Image Figure 5. Nasal Glucagon Image Figure 6. Global Glucagon Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Glucagon Market Size Share 2021 VS 2025 VS 2032 Figure 8. Emergency Kits Image Figure 9. General Use Image Figure 10. Diagnostic & Motility Image Figure 11. Cardiogenic Shock Image Figure 12. Others Image Figure 13. Global Glucagon Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Glucagon Revenue (2021-2032) & (US$ Million) Figure 15. Global Glucagon Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Glucagon Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Glucagon Revenue Market Share by Region (2021-2032) Figure 18. Global Glucagon Sales (2021-2032) & (K MT) Figure 19. Global Glucagon Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 20. Global Glucagon Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Glucagon Sales YoY (2021-2032) & (K MT) Figure 22. Europe Glucagon Sales YoY (2021-2032) & (K MT) Figure 23. China Glucagon Sales YoY (2021-2032) & (K MT) Figure 24. Asia (Excluding China) Glucagon Sales YoY (2021-2032) & (K MT) Figure 25. South America, Middle East and Africa Glucagon Sales YoY (2021-2032) & (K MT) Figure 26. Global Glucagon Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Glucagon Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Glucagon Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Glucagon Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Glucagon Revenue Market Share by Type (2021-2032) Figure 32. Global Glucagon Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 33. Global Glucagon Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Glucagon Sales Market Share by Type (2021-2032) Figure 35. Global Glucagon Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Glucagon Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Glucagon Revenue Market Share by Application (2021-2032) Figure 38. Global Glucagon Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 39. Global Glucagon Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Glucagon Sales Market Share by Application (2021-2032) Figure 41. North America Glucagon Revenue Share by Type (2021-2032) Figure 42. North America Glucagon Sales Share by Type (2021-2032) Figure 43. North America Glucagon Revenue Share by Application (2021-2032) Figure 44. North America Glucagon Sales Share by Application (2021-2032) Figure 45. North America Glucagon Revenue Share by Country (2021-2032) Figure 46. North America Glucagon Sales Share by Country (2021-2032) Figure 47. Europe Glucagon Revenue Share by Type (2021-2032) Figure 48. Europe Glucagon Sales Share by Type (2021-2032) Figure 49. Europe Glucagon Revenue Share by Application (2021-2032) Figure 50. Europe Glucagon Sales Share by Application (2021-2032) Figure 51. Europe Glucagon Revenue Share by Country (2021-2032) Figure 52. Europe Glucagon Sales Share by Country (2021-2032) Figure 53. China Glucagon Revenue Share by Type (2021-2032) Figure 54. China Glucagon Sales Share by Type (2021-2032) Figure 55. China Glucagon Revenue Share by Application (2021-2032) Figure 56. China Glucagon Sales Share by Application (2021-2032) Figure 57. Asia Glucagon Revenue Share by Type (2021-2032) Figure 58. Asia Glucagon Sales Share by Type (2021-2032) Figure 59. Asia Glucagon Revenue Share by Application (2021-2032) Figure 60. Asia Glucagon Sales Share by Application (2021-2032) Figure 61. Asia Glucagon Revenue Share by Country (2021-2032) Figure 62. Asia Glucagon Sales Share by Country (2021-2032) Figure 63. SAMEA Glucagon Revenue Share by Type (2021-2032) Figure 64. SAMEA Glucagon Sales Share by Type (2021-2032) Figure 65. SAMEA Glucagon Revenue Share by Application (2021-2032) Figure 66. SAMEA Glucagon Sales Share by Application (2021-2032) Figure 67. SAMEA Glucagon Revenue Share by Country (2021-2032) Figure 68. SAMEA Glucagon Sales Share by Country (2021-2032) Figure 69. Glucagon Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Glucagon Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Taj Pharmaceuticals
  • Xeris Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Glucagon Market by Type
  3. 1.2.1 Global Glucagon Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inject Glucagon
  5. 1.2.3 Nasal Glucagon
  6. 1.3 Glucagon Market by Application
  7. 1.3.1 Global Glucagon Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Emergency Kits
  9. 1.3.3 General Use
  10. 1.3.4 Diagnostic & Motility
  11. 1.3.5 Cardiogenic Shock
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Glucagon Market Dynamics
  1. 2.1 Glucagon Industry Trends
  2. 2.2 Glucagon Industry Drivers
  3. 2.3 Glucagon Industry Opportunities and Challenges
  4. 2.4 Glucagon Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Glucagon Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Glucagon Revenue by Region
  3. 3.2.1 Global Glucagon Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Glucagon Revenue by Region (2021-2026)
  5. 3.2.3 Global Glucagon Revenue by Region (2027-2032)
  6. 3.2.4 Global Glucagon Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Glucagon Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Glucagon Sales by Region
  9. 3.4.1 Global Glucagon Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Glucagon Sales by Region (2021-2026)
  11. 3.4.3 Global Glucagon Sales by Region (2027-2032)
  12. 3.4.4 Global Glucagon Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Glucagon Revenue by Manufacturers
  2. 4.1.1 Global Glucagon Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Glucagon Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Glucagon Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Glucagon Sales by Manufacturers
  6. 4.2.1 Global Glucagon Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Glucagon Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Glucagon Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Glucagon Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Glucagon Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Glucagon Manufacturers, Product Type & Application
  13. 4.7 Global Glucagon Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Glucagon Market CR5 and HHI
  16. 4.8.2 2025 Glucagon Tier 1, Tier 2, and Tier 3
5 Glucagon Market by Type
  1. 5.1 Global Glucagon Revenue by Type
  2. 5.1.1 Global Glucagon Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Glucagon Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Glucagon Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Glucagon Sales by Type
  6. 5.2.1 Global Glucagon Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glucagon Sales by Type (2021-2032) & (K MT)
  8. 5.2.3 Global Glucagon Sales Market Share by Type (2021-2032)
  9. 5.3 Global Glucagon Price by Type
6 Glucagon Market by Application
  1. 6.1 Global Glucagon Revenue by Application
  2. 6.1.1 Global Glucagon Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Glucagon Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Glucagon Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Glucagon Sales by Application
  6. 6.2.1 Global Glucagon Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Glucagon Sales by Application (2021-2032) & (K MT)
  8. 6.2.3 Global Glucagon Sales Market Share by Application (2021-2032)
  9. 6.3 Global Glucagon Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Glucagon Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Glucagon Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Fresenius Kabi
  14. 7.3.1 Fresenius Kabi Company Information
  15. 7.3.2 Fresenius Kabi Business Overview
  16. 7.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Kabi Glucagon Product Portfolio
  18. 7.3.5 Fresenius Kabi Recent Developments
  19. 7.4 Torrent Labs
  20. 7.4.1 Torrent Labs Company Information
  21. 7.4.2 Torrent Labs Business Overview
  22. 7.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Torrent Labs Glucagon Product Portfolio
  24. 7.4.5 Torrent Labs Recent Developments
  25. 7.5 Taj Pharmaceuticals
  26. 7.5.1 Taj Pharmaceuticals Company Information
  27. 7.5.2 Taj Pharmaceuticals Business Overview
  28. 7.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
  30. 7.5.5 Taj Pharmaceuticals Recent Developments
  31. 7.6 Xeris Pharmaceuticals
  32. 7.6.1 Xeris Pharmaceuticals Company Information
  33. 7.6.2 Xeris Pharmaceuticals Business Overview
  34. 7.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
  36. 7.6.5 Xeris Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Glucagon Market Size by Type
  2. 8.1.1 North America Glucagon Revenue by Type (2021-2032)
  3. 8.1.2 North America Glucagon Sales by Type (2021-2032)
  4. 8.1.3 North America Glucagon Price by Type (2021-2032)
  5. 8.2 North America Glucagon Market Size by Application
  6. 8.2.1 North America Glucagon Revenue by Application (2021-2032)
  7. 8.2.2 North America Glucagon Sales by Application (2021-2032)
  8. 8.2.3 North America Glucagon Price by Application (2021-2032)
  9. 8.3 North America Glucagon Market Size by Country
  10. 8.3.1 North America Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Glucagon Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Glucagon Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Glucagon Market Size by Type
  2. 9.1.1 Europe Glucagon Revenue by Type (2021-2032)
  3. 9.1.2 Europe Glucagon Sales by Type (2021-2032)
  4. 9.1.3 Europe Glucagon Price by Type (2021-2032)
  5. 9.2 Europe Glucagon Market Size by Application
  6. 9.2.1 Europe Glucagon Revenue by Application (2021-2032)
  7. 9.2.2 Europe Glucagon Sales by Application (2021-2032)
  8. 9.2.3 Europe Glucagon Price by Application (2021-2032)
  9. 9.3 Europe Glucagon Market Size by Country
  10. 9.3.1 Europe Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Glucagon Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Glucagon Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Glucagon Market Size by Type
  2. 10.1.1 China Glucagon Revenue by Type (2021-2032)
  3. 10.1.2 China Glucagon Sales by Type (2021-2032)
  4. 10.1.3 China Glucagon Price by Type (2021-2032)
  5. 10.2 China Glucagon Market Size by Application
  6. 10.2.1 China Glucagon Revenue by Application (2021-2032)
  7. 10.2.2 China Glucagon Sales by Application (2021-2032)
  8. 10.2.3 China Glucagon Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Glucagon Market Size by Type
  2. 11.1.1 Asia Glucagon Revenue by Type (2021-2032)
  3. 11.1.2 Asia Glucagon Sales by Type (2021-2032)
  4. 11.1.3 Asia Glucagon Price by Type (2021-2032)
  5. 11.2 Asia Glucagon Market Size by Application
  6. 11.2.1 Asia Glucagon Revenue by Application (2021-2032)
  7. 11.2.2 Asia Glucagon Sales by Application (2021-2032)
  8. 11.2.3 Asia Glucagon Price by Application (2021-2032)
  9. 11.3 Asia Glucagon Market Size by Country
  10. 11.3.1 Asia Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Glucagon Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Glucagon Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Glucagon Market Size by Type
  2. 12.1.1 SAMEA Glucagon Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Glucagon Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Glucagon Price by Type (2021-2032)
  5. 12.2 SAMEA Glucagon Market Size by Application
  6. 12.2.1 SAMEA Glucagon Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Glucagon Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Glucagon Price by Application (2021-2032)
  9. 12.3 SAMEA Glucagon Market Size by Country
  10. 12.3.1 SAMEA Glucagon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Glucagon Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Glucagon Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Glucagon Value Chain Analysis
  2. 13.1.1 Glucagon Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Glucagon Production Mode & Process
  6. 13.2 Glucagon Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Glucagon Distributors
  9. 13.2.3 Glucagon Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst